selected publications
-
Journal Article
- Prodromal dementia with Lewy bodies: evolution of symptoms and predictors of dementia onset. Journal of Geriatric Psychiatry and Neurology. 2022
- Responding to the needs of persons living with dementia and their caregivers during the COVID-19 pandemic: lessons from the Care Ecosystem. Innovation in aging. 2022
- A phase II, single-center, randomized, double-blind, placebo-controlled study of the safety and therapeutic efficacy of intranasal glulisine in amnestic mild cognitive impairment and probable mild Alzheimer's disease. Drugs and Aging. 2021
- Double-blind placebo-controlled pilot investigation of the safety of a single dose of rapid-acting intranasal insulin in Down syndrome. Drugs in R&D. 2020
- Screening positive for cognitive impairment: impact on healthcare utilization and provider action in primary and specialty care practices. Journal of General Internal Medicine. 2018
- NMDA receptor antibody encephalitis presenting with enhancing lesion and seizures 2017
- Routine cognitive screening in a neurology practice: effect on physician behavior 2016
- Susac syndrome with prominent dermatological findings and a prompt response to intravenous immunoglobulin, steroids, and rituximab: a case report 2016
- Metabolic disorders with clinical and radiologic features of sporadic Creutzfeldt-Jakob disease 2015
- A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein e4 carriers with mild-moderate Alzheimer's disease 2014
- The functional neuroanatomy of decision-making. Journal of Neuropsychiatry and Clinical Neurosciences. 2012
- Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology. 2011
- Safety and tolerability of galantamine SA in dementia patients transitioned from donepezil. Consultant Pharmacist. 2011
- Donepezil-associated bradyarrhythmia in a patient with dementia with Lewy bodies (DLB). Alzheimer Disease and Associated Disorders. 2010
-
Chapter
- Comportment: structure and function. Neurology and Neuropsychiatry. 2013
-
Conference Poster
- Performance on cognitive screening is associated with increased retrospective healthcare utilization [poster] 2015
- Routine cognitive screening in a neurology practice: impact on physician behavior [poster] 2015
- Failure on cognitive screening predicts increased healthcare utilization [poster] 2014
- Routine cognitive screening in a general neurology clinic: impact on physician behavior [poster] 2014
- The effect of intranasal rapid acting insulin on ApoE4 carriers with mild-moderate Alzheimer's disease [poster] 2013
- Feasibility of the mini-cog as a standardized cognitive screen in HealthPartners patients aged 70 and older [poster] 2012
- The 6th Vital Sign Project: does cognitive screening in the elderly population improve clinical care [poster]? 2012
-
Review
- Brain glucose hypometabolism and iron accumulation in different brain regions in Alzheimer's and Parkinson's diseases [review]. Pharmaceuticals (Basel, Switzerland). 2022
- Creutzfeldt-Jakob Disease in the hospital setting: a case report and review [review]. Minnesota Medicine. 2013
- The evaluation of rapidly progressive dementia [review]. The neurologist. 2011
-
Abstract
- Cognitive screening results from the Medicare annual wellness visit in a primary care practice [abstract]. Alzheimer's & dementia. 2017
- Outcomes from routine cognitive screening in a health care system [abstract]. Alzheimer's & dementia. 2016